ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The pharmaceutical services firm SK Pharmteco says it will spend $35 million to expand its facility in Swords, Ireland. The project includes a manufacturing building that will add 26.5 m3 of capacity, along with filtration and drying equipment. It is expected to open in 2024. The building will accommodate a second-phase investment with the goal of a 50% capacity expansion at the site, which SK acquired from Bristol Myers Squibb in 2017. SK put $30 million into a reactor expansion at the plant in 2020.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter